Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.82 CAD | +8.46% | +6.02% | +9.73% |
Business Summary
Number of employees: 12
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100.0
%
| 7 | 100.0 % | 6 | 100.0 % | -17.32% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Switzerland
96.0
%
| 7 | 95.7 % | 6 | 96.0 % | -17.04% |
Ireland
2.7
%
| 0 | 1.5 % | 0 | 2.7 % | +54.25% |
Other
1.1
%
| 0 | 0.1 % | 0 | 1.1 % | +1,558.79% |
Denmark
0.2
%
| 0 | 2.8 % | 0 | 0.2 % | -92.87% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 19-10-03 | |
Director of Finance/CFO | - | 22-01-23 | |
Patricia Zahn
ADM | Chief Administrative Officer | - | 15-09-30 |
Nicola Ammer
CTO | Chief Tech/Sci/R&D Officer | - | 14-01-31 |
Michael Teifel
CTO | Chief Tech/Sci/R&D Officer | - | 03-12-31 |
Matthias Gerlach
PRN | Corporate Officer/Principal | - | 00-12-31 |
Eckhard Guenther
PRN | Corporate Officer/Principal | - | 05-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gilles Gagnon
BRD | Director/Board Member | 70 | 19-12-31 |
Peter Edwards
BRD | Director/Board Member | 62 | 20-05-14 |
Dennis Turpin
BRD | Director/Board Member | - | 21-05-04 |
Carolyn Egbert
CHM | Chairman | - | 12-07-31 |
Chief Executive Officer | 60 | 19-10-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,855,876 | 4,664,308 ( 96.05 %) | 0 | 96.05 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+9.73% | 9.95M | |
+0.67% | 42.4B | |
+47.02% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |
- Stock Market
- Equities
- AEZS Stock
- Company Aeterna Zentaris Inc.